Genetic Control of Splicing at SIRPG Modulates Risk of Type 1 Diabetes

Volume: 71, Issue: 2, Pages: 350 - 358
Published: Nov 19, 2021
Abstract
Signal regulatory protein SIRPγ (CD172G) is expressed on the surface of lymphocytes, where it acts by engaging its ligand, CD47. SIRPG, which encodes SIRPγ, contains a nonsynonymous coding variant, rs6043409, which is significantly associated with risk for type 1 diabetes. SIRPG produces multiple transcript isoforms via alternative splicing, all encoding potentially functional proteins. We show that rs6043409 alters a predicted exonic splicing...
Paper Details
Title
Genetic Control of Splicing at SIRPG Modulates Risk of Type 1 Diabetes
Published Date
Nov 19, 2021
Journal
Volume
71
Issue
2
Pages
350 - 358
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.